[Edaily Reporter KIM SAE-MI ] DIO Corporation(039840)announced on the 11th that it signed a Memorandum of Understanding (MOU) on the 10th at its Busan headquarters with the Busan National University Dental Hospital and the Busan National University Industry-Academic Cooperation Foundation to conduct clinical validation and industrialize artificial intelligence (AI)-based digital dental technology.

This agreement aims to ensure the clinical reliability of the “Dental AX Platform,” which DIO Corporation is currently developing. The three institutions plan to establish a cooperative framework ranging from verifying the platform’s safety and efficacy to obtaining domestic and international medical device approvals, as well as conducting joint research and pursuing industrialization.

Under the agreement, Pusan National University Dental Hospital will verify the platform’s clinical safety and efficacy and evaluate its usability and applicability in actual clinical settings. The Pusan National University Industry-Academia Cooperation Foundation will support joint research, the planning of national research and development (R&D) projects, and the commercialization of research outcomes.

DIO Corporation will be responsible for the development, operation, and technical support of the platform under validation. The company intends to incorporate the results of clinical validation and user evaluations into its R&D to enhance the technology’s sophistication and, based on the data collected, pursue domestic and international medical device approvals and commercialization.

The three institutions plan to expand the scope of their collaboration to include identifying joint research and demonstration projects, jointly planning national R&D initiatives, training specialized personnel, and fostering academic and industrial exchanges.

Kim Jong-won, CEO of DIO Corporation, stated, “This agreement is a collaboration aimed at verifying the clinical reliability of AI-based digital dental technology and confirming its applicability in real-world clinical settings.” He added, “Through this industry-academia-hospital partnership, we will enhance the sophistication of the Dental AX Platform and develop it into a solution applicable in global healthcare settings, thereby driving DIO Corporation’s leap forward as a global total oral care platform.”